Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
YS Biopharma (YS)
NASDAQ:YS
YS Biopharma (YS) Stock Price & Analysis
65 Followers
YS Stock Chart & Stats
Day’s Range$0.9 - $1.1
52-Week Range― - ―
Previous Close$0.91
Volume107.25K
Average Volume (3M)N/A
Market Cap
$190.21M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next Earnings
Aug 13, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
YS Biopharma News
PremiumCompany Announcements
YS Biopharma Rebrands to LakeShore Biopharma
PremiumCompany Announcements
YS Biopharma Approves Major Corporate Changes
Ownership Overview
0.00%
Insiders
0.00% Mutual Funds
1.40% Other Institutional Investors
98.60% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
YS FAQ
What was YS Biopharma’s price range in the past 12 months?
Currently, no data Available
What is YS Biopharma’s market cap?
Currently, no data Available
When is YS Biopharma’s upcoming earnings report date?
YS Biopharma’s upcoming earnings report date is Aug 13, 2024 which is in 19 days.
How were YS Biopharma’s earnings last quarter?
Currently, no data Available
Is YS Biopharma overvalued?
According to Wall Street analysts YS Biopharma’s price is currently Overvalued.
Does YS Biopharma pay dividends?
YS Biopharma does not currently pay dividends.
What is YS Biopharma’s EPS estimate?
YS Biopharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does YS Biopharma have?
Currently, no data Available
What happened to YS Biopharma’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of YS Biopharma?
Among the largest hedge funds holding YS Biopharma’s share is Pinpoint Asset Management Ltd. It holds YS Biopharma’s shares valued at 36K.
---
YS Biopharma Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
YS Sentiment 100%
Sector Average 69%
Sector Average 69%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-23.48%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
5.84%
Trailing 12-Months
Company Description
YS Biopharma
Summit Healthcare Acquisition Corp is a blank check company. It is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
---
YS Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering YS
1 Year
1 Year Success Rate
1/1 ratings generated profit
1 Year Average Return
+75.80%
initiated a buy rating 9 months ago
Copying Gregory Aurand's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +75.80% per trade.
---